Dr. Reddy's Laboratories
RDY
#1736
Rank
A$17.36 B
Marketcap
A$20.77
Share price
0.29%
Change (1 day)
-6.96%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): A$1.43 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are A$3.95 Billion. In 2024 the company made an earning of A$1.34 Billion, an increase over its 2023 earnings that were of A$1.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.43 B6.69%
2024 A$1.34 B7.01%
2023 A$1.25 B17.62%
2022 A$1.06 B43.27%
2021 A$0.74 B31.44%
2020 A$0.56 B54.54%
2019 A$0.36 B-14.21%
2018 A$0.42 B26.15%
2017 A$0.33 B4.69%
2016 A$0.32 B-55.7%
2015 A$0.73 B1.83%
2014 A$0.71 B-3.78%
2013 A$0.74 B54.07%
2012 A$0.48 B-16.23%
2011 A$0.57 B56.66%
2010 A$0.36 B-235.36%
2009 -A$0.28 Billion-198.53%
2008 A$0.27 B30.77%
2007 A$0.21 B-14.61%
2006 A$0.24 B703.63%
2005 A$30.85 M649.45%
2004 A$4.11 M-95.68%
2003 A$95.21 M-14.86%
2002 A$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$17.75 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.65 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$13.96 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$24.59 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$13.63 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France